Investors piling into the Direxion Daily PLTR Bull 2X Shares (NASDAQ:PLTU) just watched their fund rip 63.76% in a single week. The catch: over the past 12 months, Palantir stock is essentially flat, yet PLTU holders are down more than a third.
That gap, between a shrugging underlying and a bleeding leveraged product, is the story behind this fund and the reason the retail crowd keeps buying it anyway.
What PLTU Actually Is
PLTU is a 2X leveraged single-stock ETF from Direxion designed to deliver daily returns of 200% of Palantir Technologies (PLTR). It is not a long-term buy-and-hold vehicle; leveraged ETFs reset their exposure every day, so multi-day returns can diverge sharply from a simple “2x the stock.” Assets have swelled to $486.9 million as of the fund’s latest NPORT filing dated April 30, 2026, with direct PLTR shares making up 20.97% of net assets and the remainder achieved through cash collateral and swap positions.
The catalyst pulling money in is obvious. Palantir’s Q2 2026 report, filed August 3, 2026, showed adjusted EPS of $0.41 versus the $0.28 consensus and revenue of $1.94 billion, up 92.83% year over year. CEO Alex Karp called the earnings report “otherworldly” and pointed to 149% U.S. commercial revenue growth as evidence the “sovereign AI” thesis is unlocking.
The One-Week Payoff
Palantir’s response to the earnings report was violent to the upside. From July 28 to August 4, 2026, PLTR climbed 31.68%, rising from $123.53 to $162.66. PLTU, doing exactly what a 2x fund is supposed to do over a short, trending stretch, jumped from $27.37 to $44.82 in that same window.
Zoom out to one month and the pattern holds: PLTR gained 25.8%, PLTU gained 46.09%. That is the fund working as advertised, and it is the version of the story getting shared on Reddit, where a post titled “Palantir posts blowout Q2 numbers, with U.S. commercial revenue soaring nearly 150%” pulled 491 upvotes and 311 comments in r/stocks.
The Decay Trap Nobody Is Posting About
Over the past year, Palantir stock returned 1.24%, moving from $160.66 on August 4, 2025 to $162.66 on August 4, 2026. A naive reader would expect a 2x fund to be up roughly 2.5%. Instead, PLTU lost 34.56%, sliding from $68.49 to $44.82.
A hypothetical $10,000 invested in PLTR one year ago would be worth roughly $10,124 today. The same $10,000 in PLTU would be worth about $6,544.
The mechanism is volatility decay. Because leveraged ETFs reset every day, a stock that swings hard and finishes near where it started still generates real losses in the fund. Palantir did exactly that: it hit $187.75 in December 2025, then bottomed at $133.02 in February 2026, then chopped its way back. Hold this fund through that kind of trip and the daily-reset math grinds capital away, even if the underlying ends the year unchanged.
Year to date, the same picture: PLTR is down 8.49%, PLTU is down 38.09%.
Why Traders Still Want It
The bull case for using PLTU lives in the day, not the year. Palantir carries a beta of 1.56 and a forward implied P/E of 133, meaning any earnings surprise or AI-adjacent headline moves the stock in double-digit chunks. Wall Street is broadly onside, with 19 buy ratings against just 1 sell and 1 strong sell, and a consensus 12-month target of $182.20. For a trader who thinks the next catalyst hits in a straight line, 2x exposure without margin is the appeal.
The problem, and it needs saying directly, is that the fund is engineered for that exact use case and nothing more. Direxion’s own prospectus language on its 2X funds warns that “the Fund will lose money if [the underlying’s] performance is flat, and it is possible that the Fund will lose money even if [the underlying’s] performance increases over a period longer than a single day.” The last 12 months of PLTU are that warning in chart form.
What to Watch Next
Palantir’s Q3 2026 revenue guide of $2.160 to $2.164 billion sets the next catalyst, with adjusted operating income guided to $1.292 to $1.296 billion. If PLTR keeps trending, PLTU keeps compounding upward. If the stock chops between its 52-week range of $106.37 to $207.52, the decay math resumes its quiet work. The fund is doing exactly what it was designed to do. The question is whether the people buying it know which version of the trade they are in.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks